[The trade-off and selection of efficacy endpoints: controversies and challenges between progression-free survival and overall survival in clinical trials of gynecological tumors].

Saved in:
Bibliographic Details
Title: [The trade-off and selection of efficacy endpoints: controversies and challenges between progression-free survival and overall survival in clinical trials of gynecological tumors].
Authors: Wang DF; Department of Gynecologic Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Sichuan Provincial Key Medical Laboratory of Gynecologic Oncology, Health Commission of Sichuan Province, Chengdu, Sichuan 610041, China., Pei J; Department of Clinical Research, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China., Zhang GN; Department of Gynecologic Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Sichuan Provincial Key Medical Laboratory of Gynecologic Oncology, Health Commission of Sichuan Province, Chengdu, Sichuan 610041, China.
Source: Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2026 Mar 03; Vol. 106 (8), pp. 687-692.
Publication Type: English Abstract; Journal Article
Journal Info: Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7511141 Publication Model: Print Cited Medium: Print ISSN: 0376-2491 (Print) Linking ISSN: 03762491 NLM ISO Abbreviation: Zhonghua Yi Xue Za Zhi Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41780995
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: [The trade-off and selection of efficacy endpoints: controversies and challenges between progression-free survival and overall survival in clinical trials of gynecological tumors].
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+DF%22">Wang DF</searchLink>; Department of Gynecologic Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Sichuan Provincial Key Medical Laboratory of Gynecologic Oncology, Health Commission of Sichuan Province, Chengdu, Sichuan 610041, China.<br /><searchLink fieldCode="AU" term="%22Pei+J%22">Pei J</searchLink>; Department of Clinical Research, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.<br /><searchLink fieldCode="AU" term="%22Zhang+GN%22">Zhang GN</searchLink>; Department of Gynecologic Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Sichuan Provincial Key Medical Laboratory of Gynecologic Oncology, Health Commission of Sichuan Province, Chengdu, Sichuan 610041, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227511141%22">Zhonghua yi xue za zhi</searchLink> [Zhonghua Yi Xue Za Zhi] 2026 Mar 03; Vol. 106 (8), pp. 687-692.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: English Abstract; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Zhonghua+yi+xue+hui%22">Zhonghua yi xue hui </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>7511141 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0376-2491 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203762491%22">03762491 </searchLink><i>NLM ISO Abbreviation: </i>Zhonghua Yi Xue Za Zhi <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41780995
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3760/cma.j.cn112137-20251220-03362
    Languages:
      – Code: chi
        Text: Chinese
    PhysicalDescription:
      Pagination:
        StartPage: 687
    Titles:
      – TitleFull: [The trade-off and selection of efficacy endpoints: controversies and challenges between progression-free survival and overall survival in clinical trials of gynecological tumors].
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang DF
      – PersonEntity:
          Name:
            NameFull: Pei J
      – PersonEntity:
          Name:
            NameFull: Zhang GN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 03
              Text: 2026 Mar 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 0376-2491
          Numbering:
            – Type: volume
              Value: 106
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Zhonghua yi xue za zhi
              Type: main
ResultId 1